Mahlangu, Johnny <br/><br/>
Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.  [electronic resource] 

 -  Blood  Jan 2014 
 - 317-25 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2013-10-529974  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Child<br/>Drug Administration Schedule<br/>Factor VIII--pharmacokinetics<br/>Hemophilia A--drug therapy<br/>Hemorrhage--drug therapy<br/>Humans<br/>Immunoglobulin Fc Fragments--therapeutic use<br/>Male<br/>Middle Aged<br/>Recombinant Fusion Proteins--pharmacokinetics<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult